Does Monte Rosa Therapeutics' (GLUE) Shift Into Russell Growth Indices Recast Its Biotech Risk Profile?
Monte Rosa Therapeutics, Inc. (NasdaqGS: GLUE) was recently removed from several Russell Value benchmarks and added to multiple Russell Growth benchmarks, including the Russell 2000 Growth, 2500 Growth, 3000 Growth, 3000E Growth, Small Cap Comp Growth, and Microcap Growth indices. This broad shift from Value to Growth classifications across the Russell index family highlights a change in how index providers now categorize Monte Rosa’s profile within the small-cap biotech universe. We’ll now...
Monte Rosa Therapeutics, Inc. (NasdaqGS: GLUE) was recently removed from several Russell Value benchmarks and added to multiple Russell Growth benchmarks, including the Russell 2000 Growth, 2500 Growth, 3000 Growth, 3000E Growth, Small Cap Comp Growth, and Microcap Growth indices.
This broad shift from Value to Growth classifications across the Russell index family highlights a change in how index providers now categorize Monte Rosa’s profile within the small-cap biotech universe.
We’ll now...
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
